Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP4K4 | O95819 | 3/20 | 0.48 |
| ▸ | GAK | O14976 | 1/20 | 0.48 |
| ▸ | RIPK2 | O43353 | 1/20 | 0.48 |
| ▸ | ULK1 | O75385 | 1/20 | 0.48 |
| ▸ | STK10 | O94804 | 1/20 | 0.48 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.48 |
| ▸ | LATS1 | O95835 | 1/20 | 0.48 |
| ▸ | PAK4 | O96013 | 1/20 | 0.48 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.48 |
| ▸ | LCK | P06239 | 1/20 | 0.48 |
| ▸ | CDK1 | P06493 | 1/20 | 0.48 |
| ▸ | APRT | P07741 | 1/20 | 0.48 |
| ▸ | RET | P07949 | 1/20 | 0.48 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.48 |
| ▸ | PHKG2 | P15735 | 1/20 | 0.48 |
| ▸ | NQO2 | P16083 | 1/20 | 0.48 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.48 |
| ▸ | FECH | P22830 | 1/20 | 0.48 |
| ▸ | CDK2 | P24941 | 1/20 | 0.48 |
| ▸ | MARK3 | P27448 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25297997 | 0.90 | CKS1B (0.48) | MAP4K4GAKRIPK2ULK1STK10 | |
| SCHEMBL29450886 | 0.90 | CKS1B (0.48) | MAP4K4GAKRIPK2ULK1STK10 | |
| SCHEMBL5764652 | 0.90 | MAP4K4 (0.47) | MAP4K4GAKRIPK2ULK1STK10 | |
| SCHEMBL3842680 | 0.90 | IRAK4 (0.52) | MAP4K4GAKRIPK2ULK1STK10 | |
| SCHEMBL5764136 | 0.90 | CKS1B (0.51) | MAP4K4GAKRIPK2ULK1STK10 | |
| SCHEMBL5767031 | 0.87 | MAP4K4 (0.44) | MAP4K4GAKRIPK2ULK1STK10 | |
| SCHEMBL5767002 | 0.87 | MAP4K4 (0.46) | MAP4K4GAKRIPK2ULK1STK10 | |
| SCHEMBL5766850 | 0.86 | MAP4K4 (0.45) | MAP4K4GAKRIPK2ULK1STK10 | |
| SCHEMBL5766532 | 0.86 | MAP4K4 (0.54) | MAP4K4GAKRIPK2ULK1STK10 | |
| SCHEMBL5766013 | 0.86 | MAP4K4 (0.49) | MAP4K4GAKRIPK2ULK1STK10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1594858-B1 | NOVEL BENZOIMIDAZOLE DERIVATIVES USEFUL AS ANTIPROLIFERATIVE AGENTS | PFIZER PROD INC (US) | 2009-10-14 | — | — | EP | disclosed |
| US-7071337-B2 | Benzoimidazole derivatives useful as antiproliferative agents | PFIZER INC (US) | 2006-07-04 | — | — | US | disclosed |
| US-7019147-B1 | Benzimidazole derivatives useful as antiproliferative agents | PFIZER INC. (US) | 2006-03-28 | — | — | US | disclosed |
| EP-1235825-B1 | NOVEL BENZOIMIDAZOLE DERIVATIVES USEFUL AS ANTIPROLIFERATIVE AGENTS | PFIZER PROD INC (US) | 2006-01-25 | — | — | EP | disclosed |
| EP-1594858-A2 | NOVEL BENZOIMIDAZOLE DERIVATIVES USEFUL AS ANTIPROLIFERATIVE AGENTS | Pfizer Products Inc. (US) | 2005-11-16 | — | — | EP | disclosed |
| US-20050124599-A1 | Novel benzoimidazole derivatives useful as antiproliferative agents | PFIZER INC. | 2005-06-09 | — | — | US | disclosed |
| WO-2004020431-A2 | NOVEL BENZOIMIDAZOLE DERIVATIVES USEFUL AS ANTIPROLIFERATIVE AGENTS | PFIZER PRODUCTS INC. (US) | 2004-03-11 | — | — | WO | disclosed |
| EP-1235825-A1 | NOVEL BENZOIMIDAZOLE DERIVATIVES USEFUL AS ANTIPROLIFERATIVE AGENTS | Pfizer Products Inc. (US) | 2002-09-04 | — | — | EP | disclosed |
| WO-2001040217-A1 | NOVEL BENZOIMIDAZOLE DERIVATIVES USEFUL AS ANTIPROLIFERATIVE AGENTS | PFIZER PRODUCTS INC. (US) | 2001-06-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050124599-A1 | Novel benzoimidazole derivatives useful as antiproliferative agents | CCNI, CCNT1, CCNA1 | MAP4K4 1460/4885GAK 526/4885RIPK2 3316/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.